Group 1 - The innovative drug sector has been actively rising since the end of July, with significant increases in various sub-concept indices [1] - A substantial amount of capital has flowed into the innovative drug field through ETFs, with a total net inflow of 7.551 billion yuan in August [1] - 24 innovative drug ETFs, including QDII, have recorded gains in August, with nearly 80% of them experiencing net inflows [1] Group 2 - The Huatai-PineBridge Hong Kong Innovative Drug ETF saw a net inflow of 2.829 billion yuan in August, leading the sector [1] - The GF CSI Hong Kong Innovative Drug ETF followed closely with a net inflow of 2.711 billion yuan [1] - Other ETFs such as the Hong Kong Innovative Drug ETF, Invesco Great Wall CSI Hong Kong Innovative Drug ETF, and GF Innovative Drug ETF also reported significant net inflows [1]
创新药ETF获资金青睐
Zheng Quan Shi Bao Wang·2025-08-18 03:54